THE PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES (MDS) FOLLOWING G-CSF

被引：0
|
作者：
LEBEAU, M
TAYLOR, K
LARSON, R
KOEFFLER, P
NEGRIN, R
SABA, H
GANSER, A
JAKUBOWSKI, A
GABRILOVE, J
MUFTI, GJ
CRUZ, J
LANGLEY, G
VARDIMAN, J
DAVIS, M
GREENBERG, P
机构：
[1] UNIV CHICAGO, CHICAGO, IL 60637 USA
[2] MATER HOSP, BRISBANE, AUSTRALIA
[3] UNIV CALIF LOS ANGELES, LOS ANGELES, CA USA
[4] MOFFITT CANC CTR, TAMPA, FL USA
[5] GOETHE UNIV, FRANKFURT, GERMANY
[6] MEM HOSP, ALBANY, NY USA
[7] UNIV LONDON KINGS COLL HOSP, LONDON SE5 8RX, ENGLAND
[8] WAKE FOREST CANC CTR, WINSTON SALEM, NC USA
[9] VICTORIA GEN HOSP, HALIFAX B3H 2Y9, NS, CANADA
[10] AMGEN INC, THOUSAND OAKS, CA USA
[11] STANFORD UNIV HOSP, STANFORD, CA 94305 USA
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A375 / A375
页数：1
相关论文
共 50 条
  • [31] CYTOGENETIC ABNORMALITIES IN CHILDHOOD ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME AND PROGNOSTIC SIGNIFICANCE
    Baka, M.
    Servitzoglou, M.
    Divane, A.
    Pourtsidis, A.
    Bouhoutsou, D.
    Varvoutsi, M.
    Doganis, D.
    Dana, H.
    Panagopoulou, P.
    Kosmidis, H.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 236 - 236
  • [32] Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
    Yan, Xuefen
    Wang, Lu
    Jiang, Lingxu
    Luo, Yingwan
    Lin, Peipei
    Yang, Wenli
    Ren, Yanling
    Ma, Liya
    Zhou, Xinping
    Mei, Chen
    Ye, Li
    Xu, Gaixiang
    Xu, Weilai
    Yang, Haiyang
    Lu, Chenxi
    Jin, Jie
    Tong, Hongyan
    CANCER MEDICINE, 2021, 10 (05): : 1759 - 1771
  • [33] Clinical Significance of Cytogenetic Manifestations in Myelodysplastic Syndromes
    Navada, Shyamala C.
    Chatalbash, Allison
    Silverman, Lewis R.
    LABMEDICINE, 2013, 44 (02): : 103 - 107
  • [34] MYELODYSPLASTIC SYNDROMES - DIAGNOSTIC AND PROGNOSTIC-SIGNIFICANCE OF IMMUNOHISTOCHEMICAL ASSESSMENT OF BONE-MARROW TREPHINES
    MANGI, MH
    SALISBURY, JR
    MUFTI, GJ
    JOURNAL OF PATHOLOGY, 1990, 161 (04): : A344 - A344
  • [35] PROGNOSTIC-SIGNIFICANCE OF ABNORMAL REGIONAL HYPERMETHYLATION OF THE CALCITONIN-GENE IN PRIMARY MYELODYSPLASTIC SYNDROMES
    DHODAPKAR, MV
    GRILL, JP
    LUST, JA
    BLOOD, 1993, 82 (10) : A552 - A552
  • [36] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
    Bacher, Ulrike
    Schnittger, Susanne
    Kern, Wolfgang
    Weiss, Tamara
    Haferlach, Torsten
    Haferlach, Claudia
    ANNALS OF HEMATOLOGY, 2009, 88 (12) : 1207 - 1213
  • [37] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
    Ulrike Bacher
    Susanne Schnittger
    Wolfgang Kern
    Tamara Weiss
    Torsten Haferlach
    Claudia Haferlach
    Annals of Hematology, 2009, 88 : 1207 - 1213
  • [38] Prognostic relevance of cytogenetic systems in myelodysplastic syndromes
    Belli, Carolina B.
    Bestach, Yesica
    Correa, Walter A.
    Sakamoto, Francisco
    Flores, Maria G.
    Basquiera, Ana L.
    Rivas, Maria M.
    Campestri, Reinaldo
    Bengio, Raquel
    Larripa, Irene
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1640 - 1642
  • [39] Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure
    West, RR
    Stafford, DA
    White, AD
    Bowen, DT
    Padua, RA
    BLOOD, 2000, 95 (06) : 2093 - 2097
  • [40] Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes
    Olney, Harold J.
    Le Beau, Michelle M.
    LEUKEMIA RESEARCH, 2007, 31 (04) : 427 - 434
12345